Richard Ward Selected Research

Richard Ward Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 11/2010
5	Iron Overload 01/2023 - 08/2019
5	Sickle Cell Anemia (Hemoglobin S Disease) 06/2021 - 07/2014
3	Infections 01/2020 - 08/2007
3	Gastroenteritis 04/2009 - 11/2006
3	Rotavirus Infections 03/2009 - 07/2007
2	Chronic Renal Insufficiency 09/2023 - 11/2016
2	Dementia (Dementias) 11/2022 - 11/2021
2	Carcinogenesis 11/2020 - 01/2016
2	Atrial Fibrillation 07/2018 - 10/2014
2	Pain (Aches) 01/2018 - 07/2014
2	Hypertension (High Blood Pressure) 09/2011 - 05/2009
1	beta-Thalassemia (Cooley's Anemia) 01/2024
1	Cardiomyopathies (Cardiomyopathy) 01/2024
1	Gout 11/2023
1	Gouty Arthritis 11/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Thrombocytopenia (Thrombopenia) 06/2021
1	Hypovolemia 06/2021
1	Splenomegaly 06/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Fever (Fevers) 01/2020
1	Neutropenia 08/2019
1	Hemochromatosis (Bronze Diabetes) 08/2019
1	Agranulocytosis (Granulocytopenia) 08/2019
1	Thalassemia 01/2019
1	Stroke (Strokes) 07/2018
1	Chronic Pain 11/2016
1	Atherosclerosis 11/2016
1	Abdominal Aortic Aneurysm 11/2016
1	Body Weight (Weight, Body) 01/2015
1	Nausea 07/2014
1	Headache (Headaches) 07/2014
1	Abdominal Pain (Pain, Abdominal) 07/2014
1	Vomiting 07/2014
1	Fatigue 07/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2013
1	Obesity 12/2013
1	Substance-Related Disorders (Drug Abuse) 12/2013
1	Feeding and Eating Disorders (Eating Disorder) 12/2013
1	Anemia 10/2013
1	Retinoblastoma (Glioblastoma, Retinal) 01/2013

Drug/Important Bio-Agent (IBA)

7	IronIBA 01/2024 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 06/2021 - 01/2019
2	GlobinsIBA 01/2019 - 07/2014
2	AnticoagulantsIBA 07/2018 - 10/2014
2	raf KinasesIBA 01/2015 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2015 - 01/2015
2	VaccinesIBA 04/2009 - 11/2006
1	Chelating AgentsIBA 01/2024
1	Gout Suppressants (Antigout Agents)IBA 11/2023
1	potassium oxonateIBA 11/2023
1	BenzbromaroneIBA 11/2023
1	Uric Acid (Urate)IBA 11/2023
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2023
1	4-amino-TEMPO (A-TEMPO)IBA 11/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	dictamnineIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	osimertinibIBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	NexusIBA 11/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 03/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	DeferiproneIBA 08/2019
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	LDL CholesterolIBA 11/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016
1	Opioid Analgesics (Opioids)IBA 11/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2016
1	Lysophosphatidic Acid ReceptorsIBA 01/2016
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2016
1	LigandsIBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	Ferritins (Ferritin)IBA 01/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	2,2-dimethylbutyric acidIBA 07/2014
1	Fetal Hemoglobin (Hemoglobin F)IBA 07/2014
1	Volatile Fatty AcidsIBA 07/2014
1	Orexin ReceptorsIBA 12/2013
1	OrexinsIBA 12/2013
1	Orexin Receptor AntagonistsIBA 12/2013
1	Peptide Receptors (Peptide Receptor)IBA 12/2013
1	Histones (Histone)IBA 01/2013
1	Histone ChaperonesIBA 01/2013

Therapy/Procedure

9	Therapeutics 12/2021 - 03/2008
3	Chelation Therapy (Therapy, Chelation) 01/2024 - 10/2013
1	Injections 11/2023
1	Intraperitoneal Injections 11/2023
1	Renal Dialysis (Hemodialysis) 09/2023
1	Transitional Care 09/2018
1	Erythrocyte Transfusion 11/2015